Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: A retrospective study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Cho, Sung Yeon ^a   Lee, Dong Gun ^a,b   Choi, Su Mi ^a   Kwon, Jae Cheol ^c   Kim, Si Hyun ^d   Choi, Jae Ki ^a   Park, Sun H ^a   Park, Yeon Joon ^a   Choi, Jung Hyun ^a   Yoo, Jin Hong ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Daniel Hospital   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Bacteremia; Enterococcus; Mortality; Neutropenia; Risk factors; Vancomycin resistance

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LINEZOLID; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STEM CELL TRANSPLANTATION; THERAPY DELAY; TREND STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN SUSCEPTIBLE ENTEROCOCCUS; BACTEREMIA; BLOOD; DRUG EFFECTS; GRAM POSITIVE INFECTION; HEMATOLOGIC DISEASE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; RISK FACTOR;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84886406070     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-504     Document Type: Article

References (35)

1. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005, 41:327-333. 10.1086/430909, 16007529.
2. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: Why are they here, and where do they come from?. Lancet Infect Dis 2001, 1:314-325. 10.1016/S1473-3099(01)00145-1, 11871804.
3. Moellering RC. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992, 14:1173-1176. 10.1093/clinids/14.6.1173, 1623072.
4. Kwon JC, Kim SH, Choi JK, Cho SY, Park YJ, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. Epidemiology and clinical features of bloodstream infections in hematological wards: one year experience at the catholic blood and marrow transplantation center. Infect Chemother 2013, 45:51-61.
5. McKinnell JA, Patel M, Shirley RM, Kunz DF, Moser SA, Baddley JW. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. Epidemiol Infect 2011, 139:1342-1350. 10.1017/S0950268810002475, 21073764.
6. Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CO, Yong D, Choi JY, Song YG, Lee K, Kim JM. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect 2009, 58:182-190. 10.1016/j.jinf.2009.01.013, 19233476.
7. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995, 172:993-1000. 10.1093/infdis/172.4.993, 7561221.
8. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001, 135:484-492. 10.7326/0003-4819-135-7-200110020-00007, 11578151.
9. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996, 23:1234-1239. 10.1093/clinids/23.6.1234, 8953064.
10. Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000, 36:145-158. 10.1016/S0732-8893(99)00136-4, 10729656.
11. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002, 34:922-929. 10.1086/339211, 11880957.
12. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005, 191:588-595. 10.1086/427512, 15655783.
13. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, Kusne S. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996, 22:663-670. 10.1093/clinids/22.4.663, 8729206.
14. Kamboj M, Chung D, Seo SK, Pamer EG, Sepkowitz KA, Jakubowski AA, Papanicolaou G. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant 2010, 16:1576-1581. 10.1016/j.bbmt.2010.05.008, 3670412, 20685257.
15. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999, 20:318-323. 10.1086/501624, 10349947.
16. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998, 26:1127-1133. 10.1086/520311, 9597241.
17. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000, 30:466-472. 10.1086/313694, 10722429.
18. Yoo JH, Lee DG, Choi SM, Choi JH, Shin WS, Kim M, Yong D, Lee K, Min WS, Kim CC. Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course. J Korean Med Sci 2005, 20:169-176. 10.3346/jkms.2005.20.2.169, 2808587, 15831982.
19. Todeschini G, Tecchio C, Borghero C, D'Emilio A, Pegoraro E, de Lalla F, Benedetti P, Spolaore P, Pellizzer G. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. J Infect 2006, 53:266-273. 10.1016/j.jinf.2005.11.012, 16388852.
20. Lee DG, Kim SH, Kim SY, Kim C, Park WB, Song YG, Choi JH. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 2011, 26:220-252. 10.3904/kjim.2011.26.2.220, 3110859, 21716917.
21. Weissinger F, Auner HW, Bertz H, Buchheidt D, Cornely OA, Egerer G, Heinz W, Karthaus M, Kiehl M, Krüger W, Penack O, Reuter S, Ruhnke M, Sandherr M, Salwender HJ, Ullmann AJ, Waldschmidt DT, Wolf HH. Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation-guidelines of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO). Ann Hematol 2012, 91:1161-1174. 10.1007/s00277-012-1456-8, 22638755.
22. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Biol Blood Marrow Transplant 2009, 15:1143-1238. 10.1016/j.bbmt.2009.06.019, 3103296, 19747629.
23. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Infectious Diseases Society of America Clinical practice guidelines for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011, 52:e56-e93. 10.1093/cid/cir073, 21258094, Infectious Diseases Society of America.
24. Lee DG, Yim DS, Choi SM, Park SH, Yoo JH, Choi JH, Min WS, Shin WS, Kim CC. Efficacies of teicoplanin in patients with febrile neutropenia. Infect Chemother 2004, 36:83-91.
25. Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martínez JA, Carreras E, Mensa J. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005, 84:40-46. 10.1007/s00277-004-0909-0, 15480665.
26. Kim SH, Kwon JC, Choi SM, Lee DG, Park SH, Choi JH, Yoo JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome. Ann Hematol 2013, 92:533-541. 10.1007/s00277-012-1631-y, 23161391.
27. Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ, Young JH. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012, 55:764-770. 10.1093/cid/cis550, 3657510, 22693346.
28. Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D. Differing risk factors for vancomycin-resistance and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect 2012, 18:388-394. 10.1111/j.1469-0691.2011.03591.x, 21848977.
29. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, Calderwood SB, Ausubel FM. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA 2001, 98:10892-10897. 10.1073/pnas.191378698, 58570, 11535834.
30. Nannini EC. Vancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapy. Clin Infect Dis 2006, 42:1203-1204. 10.1086/502653, 16575743.
31. Rakita RM, Vanek NN, Jacques-Palaz K, Mee M, Mariscalco MM, Dunny GM, Snuggs M, Van Winkle WB, Simon SI. Enterococcus faecalis bearing aggregation substance is resistant to killing by human neutrophils despite phagocytosis and neutrophil activation. Infect Immun 1999, 67:6067-6075. 96994, 10531268.
32. Arduino RC, Jaques-Palaz K, Murray BE, Rakita RM. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect Immun 1994, 62:5587-5594. 303306, 7960141.
33. Worth LJ, Thursky KA, Seymour JF, Slavin MA. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007, 79:226-233. 10.1111/j.1600-0609.2007.00911.x, 17655696.
34. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-140. 10.1016/0196-6553(88)90053-3, 2841893.
35. Weinstock DM, Conlon M, Iovino D, Aubrey T, Gudiol C, Riedel E, Young JW, Kiehn TE, Zuccotti G. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007, 13:615-621. 10.1016/j.bbmt.2007.01.078, 17448922.